Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL4367446

COC.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.71
TP53 P04637 1/20 0.47
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
CYP2C9 P11712 1/20 0.38
PDE4A P27815 1/20 0.38
PGD P52209 2/20 0.37
OR51E2 Q9H255 1/20 0.33
CYP3A4 P08684 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL4778934 0.85 TSHR (0.83) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL8945831 0.85 TSHR (0.83) TSHRTP53NFKB1CYP2C19CYP2C9
Tartaric Acid SCHEMBL5762 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL1062721 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL31427568 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL22768 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL116846 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL1431070 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Cadaverine Tartrate SCHEMBL848 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9
Tartaric Acid SCHEMBL29430365 0.84 TSHR (1.00) TSHRTP53NFKB1CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090292018-A1 Dicarbonic Acid Derivatives, Metastasis Inhibitors and Agents Increasing Chemotherapeutic Activity of Anti-Tumor Preparations, Method for Enhancing the Cytostatic Efficiency and Metastasis Process Inhibiting Method INSTITUT PROBLEM KHIMICHESKOI FITZIKI ROSSIISKOI AKADEMII NAUK (RU) 2009-11-26 US disclosed
US-20080214671-A1 Dicarbonic Acid Derivatives, Metastasis Inhibitors and Agents Increasing Chemotherapeutic Activity of Anti-Tumor Preparations, Method for Enhancing the Cytostatic Efficiency and Metastasis Process Inhibiting Method INSTITUT PROBLEM KHIMICHESKOI FIZIKI ROSSIISKOI AKADEMII NAUK (RU) 2008-09-04 US disclosed
EP-1894916-A2 DICARBONIC ACID DERIVATIVES, METASTASIS INHIBITORS AND AGENTS INCREASING CHEMOTHERAPEUTIC ACTIVITY OF ANTI-TUMOR PREPARATIONS, METHOD FOR ENHANCING THE EFFICIENCY OF CYTOSTATICS AND METASTASIS PROCESS INHIBITING METHOD Institut Problem Khimicheskoi Fiziki Rossiiskoi AK (RU) 2008-03-05 EP disclosed
US-4782005-A N,N'-diorgano dicarboxamides as oxygen inhibitors in radiation sensitive acrylate compositions POLYCHROME CORP. (US) 1988-11-01 US disclosed